Category: News

TWC received regulatory approval to acquire the Cibolo Valley wastewater system. The transaction is expected to close Nov. 1, 2026.

Vireo announced the indirect acquisition of M3 Wellness, a dispensary located in Hawthorne, Nevada.

AUSTIN, TX, Sept. 21, 2026 (GLOBE NEWSWIRE) — Forward Industries, Inc. (NASDAQ: FWDI) (the “Company” or “Forward”), the leading Solana treasury company, today provided an update on its SOL treasury holdings.

Howard Community College Professor and Department Head of Engineering Dr. Ghazanfer Bozai will serve as the inaugural holder for a five-year term beginning this fall.

Howard Community College Professor and Department Head of Engineering Dr. Ghazanfer Bozai will serve as the inaugural holder for a five-year term beginning this fall.

SAN FRANCISCO, Sept. 21, 2026 (GLOBE NEWSWIRE) — Sutter Health today announced that Christina Oh has been named executive vice president and chief operating officer. She will expand her operational leadership role at the not-for-profit, integrated health system as it continues to enhance access, strengthen performance and advance more coordinated and advanced clinical care close to home for patients and communities.

The Global Data Catalog Market is Segmented by Component, Deployment Mode, Enterprise Size, End User, Region, and Forecast 2026-2035

Gold, Silver, and Clad Coins Honor Therapy Dogs, Guide and Service Dogs, and Military and Law Enforcement K9s; Surcharges Will Support America’s VetDogs

Gold, Silver, and Clad Coins Honor Therapy Dogs, Guide and Service Dogs, and  Military and Law Enforcement K9s; Surcharges Will Support America’s VetDogs

The launch of emerging therapies such as ILUMYA/ILUMETRI (tildrakizumab-asmn; Sun Pharma), Izokibep (Affibody Medical), ICOTYDE (icotrokinra; Johnson & Johnson), Zasocitinib (TAK-279; Takeda), Sonelokimab (MoonLake Immunotherapeutics), Vunakizumab (Suzhou Suncadia), SPY 072 (Spyre Therapeutics), PN-881 (Protagonist Therapeutics), and others is expected to significantly reshape the Psoriatic Arthritis (PsA) market by expanding treatment options and addressing unmet needs among patients with inadequate responses to existing therapies.

The launch of emerging therapies such as ILUMYA/ILUMETRI (tildrakizumab-asmn; Sun Pharma), Izokibep (Affibody Medical), ICOTYDE (icotrokinra; Johnson & Johnson), Zasocitinib (TAK-279; Takeda), Sonelokimab (MoonLake Immunotherapeutics), Vunakizumab (Suzhou Suncadia), SPY 072 (Spyre Therapeutics), PN-881 (Protagonist Therapeutics), and others is expected to significantly reshape the Psoriatic Arthritis (PsA) market by expanding treatment options and addressing unmet needs among patients with inadequate responses to existing therapies.

Paris, 21 septembre 2026 – (Article 5 du règlement (UE) n° 596/2014 sur les abus de marché et Article 3 (3) du règlement délégué (UE) 2016/1052 complétant le règlement (UE) n° 596/2014 par des normes techniques de réglementation concernant les conditions applicables aux programmes de rachat et aux mesures de stabilisation).

Basel, 21 September 2026 – Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the European Commission has approved Susvimo® (ranibizumab 100 mg/mL solution for injection) for the treatment of neovascular age-related macular degeneration (nAMD), a leading cause of vision loss in people over the age of 60.^5,6 

Montrouge, le 21 septembre 2026

Drawing on 60-plus interviews, the research points to trusted information, stronger networks, and easier cross-border giving as the keys to greater impact.

Drawing on 60-plus interviews, the research points to trusted information, stronger networks, and easier cross-border giving as the keys to greater impact.

Northmarq announces the acquisition of Thirdline Capital Management, a registered investment advisor that manages the Thirdline Real Estate Income Fund.

Second campus under the Company’s 99 MW Alberta program; site offers 3 MW of grid power and a natural gas interconnection for behind-the-meter generation, planned as a 9.9 MW campus for AI and high-performance computing clients

GREENWICH, Conn., Sept. 21, 2026 (GLOBE NEWSWIRE) — XPO (NYSE: XPO), a leading provider of freight transportation in North America, has been named to the 2027 FreightTech 100 list by FreightWaves, a global provider of supply chain market intelligence. XPO has been included on the FreightTech 100 every year since the inception of the list, which recognizes the most innovative companies in the freight transportation industry.

Selection comes as campus celebrates 60 years serving the Dallas-Fort Worth Area

Selection comes as campus celebrates 60 years serving the Dallas-Fort Worth Area

Not for distribution to U.S. newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, into the United States

Not for distribution to U.S. newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, into the United States

Tarrytown, New York, USA, Sept. 21, 2026 (GLOBE NEWSWIRE) —

Siemens Healthineers and Novo have announced a collaboration focused on advancing care for people living with metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH). The companies are engaged in several projects to strengthen disease awareness, support earlier assessment of the disease, and help expand patient access to non-invasive blood testing.

Johnson & Johnson introduces the first IL-23R targeted oral peptide that can deliver skin clearance and a favourable safety profile in a once-daily pill.^1,2